| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
phenotype | 0.540 | None | 0.833 | 1 | 0 | 2011 | 2019 | ||||||||
|
carbonic anhydrase 3 | 0.682 | 0.500 | 1.7E-03 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2014 | 2015 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
phenotype | 0.400 | None | 0.900 | 1 | 0 | 2009 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily B member 6 | 0.428 | 0.846 | 1.9E-10 |
|
phenotype | 0.380 | None | 0.889 | 1 | 0 | 2007 | 2018 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
phenotype | 0.370 | None | 1.000 | 1 | 0 | 2010 | 2019 | ||||||||
|
glutathione S-transferase mu 2 | 0.488 | 0.808 | 3.4E-07 |
|
phenotype | 0.350 | None | 1.000 | 1 | 0 | 2001 | 2014 | ||||||||
|
apolipoprotein A1 | 0.429 | 0.885 | 5.5E-04 |
|
phenotype | 0.320 | None | 1.000 | 1 | 0 | 2005 | 2017 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
phenotype | 0.320 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
keratin 18 | 0.530 | 0.692 | 0.73 |
|
phenotype | 0.320 | None | 1.000 | 1 | 0 | 1997 | 2017 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
phenotype | 0.320 | None | 1.000 | 1 | 0 | 1993 | 2017 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
growth arrest and DNA damage inducible alpha | 0.526 | 0.769 | 4.4E-02 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2019 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2014 | ||||||||
|
ATP binding cassette subfamily C member 1 | 0.445 | 0.808 | 1.2E-03 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2020 | ||||||||
|
secretory leukocyte peptidase inhibitor | 0.449 | 0.846 | 9.0E-04 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2017 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 10 | 0.378 | 0.885 | 0.37 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2001 | 2018 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2012 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2015 | 2019 | ||||||||
|
carbamoyl-phosphate synthase 1 | 0.590 | 0.615 | 1.1E-09 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2015 | ||||||||
|
cytochrome P450 family 3 subfamily A member 4 | 0.462 | 0.885 | 5.8E-11 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2018 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2017 | ||||||||
|
nuclear receptor subfamily 5 group A member 2 | 0.563 | 0.731 | 0.24 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2015 | 2018 | ||||||||
|
cytochrome P450 family 1 subfamily A member 2 | 0.494 | 0.923 | 2.5E-10 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2018 |